View in EDS HTML Full Text PDF Full Text

Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.

Saved in:
Bibliographic Details
Title: Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.
Authors: Tanaka Y; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan. yuuki-tanaka@taiho.co.jp., Wada H; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Goto R; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Osada T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Yamamura K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Fukaya S; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Shimizu A; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Okubo M; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Minamiguchi K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Ikizawa K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Sasaki E; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan., Utsugi T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
Source: Scientific reports [Sci Rep] 2022 Apr 12; Vol. 12 (1), pp. 6082. Date of Electronic Publication: 2022 Apr 12.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35414003
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan. yuuki-tanaka@taiho.co.jp.<br /><searchLink fieldCode="AU" term="%22Wada+H%22">Wada H</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+R%22">Goto R</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Osada+T%22">Osada T</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamura+K%22">Yamamura K</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Fukaya+S%22">Fukaya S</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Shimizu+A%22">Shimizu A</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Okubo+M%22">Okubo M</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Minamiguchi+K%22">Minamiguchi K</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Ikizawa+K%22">Ikizawa K</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+E%22">Sasaki E</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Utsugi+T%22">Utsugi T</searchLink>; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2022 Apr 12; Vol. 12 (1), pp. 6082. <i>Date of Electronic Publication: </i>2022 Apr 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35414003
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-022-10374-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6082
    Titles:
      – TitleFull: Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tanaka Y
      – PersonEntity:
          Name:
            NameFull: Wada H
      – PersonEntity:
          Name:
            NameFull: Goto R
      – PersonEntity:
          Name:
            NameFull: Osada T
      – PersonEntity:
          Name:
            NameFull: Yamamura K
      – PersonEntity:
          Name:
            NameFull: Fukaya S
      – PersonEntity:
          Name:
            NameFull: Shimizu A
      – PersonEntity:
          Name:
            NameFull: Okubo M
      – PersonEntity:
          Name:
            NameFull: Minamiguchi K
      – PersonEntity:
          Name:
            NameFull: Ikizawa K
      – PersonEntity:
          Name:
            NameFull: Sasaki E
      – PersonEntity:
          Name:
            NameFull: Utsugi T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 04
              Text: 2022 Apr 12
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1